COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021 Nov 9, 2021
COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360… Nov 9, 2021
COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for post-traumatic stress disorder Nov 3, 2021
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021 Aug 11, 2021
COMPASS Pathways Teams with UK Institutions to Research Innovations in Mental Health Care Jul 7, 2021
COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to… Jul 5, 2021